These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17414233)

  • 1. Is it easier to find what you are looking for if you think you know what it looks like?
    Mundt JC; Greist JH; Jefferson JW; Katzelnick DJ; DeBrota DJ; Chappell PB; Modell JG
    J Clin Psychopharmacol; 2007 Apr; 27(2):121-5. PubMed ID: 17414233
    [No Abstract]   [Full Text] [Related]  

  • 2. They are from the government and they really are here to help you.
    Woosley RL
    J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889
    [No Abstract]   [Full Text] [Related]  

  • 3. Food and drug administration expanded access to treatment: implications for oncology patients.
    Freedman RS; Markman M
    Cancer; 2007 Jun; 109(11):2157-60. PubMed ID: 17450587
    [No Abstract]   [Full Text] [Related]  

  • 4. Elevated C-reactive protein in depression: a predictor of good long-term outcome with antidepressants and poor outcome with psychotherapy.
    Harley J; Luty S; Carter J; Mulder R; Joyce P
    J Psychopharmacol; 2010 Apr; 24(4):625-6. PubMed ID: 19282426
    [No Abstract]   [Full Text] [Related]  

  • 5. Protocol design.
    Wilensky AJ
    Epilepsy Res Suppl; 1993; 10():107-13. PubMed ID: 8251086
    [No Abstract]   [Full Text] [Related]  

  • 6. Transcranial magnetic stimulation for depression.
    Technol Eval Cent Assess Program Exec Summ; 2009 Oct; 24(5):1-3. PubMed ID: 20183931
    [No Abstract]   [Full Text] [Related]  

  • 7. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 8. Science and regulatory rituals associated with the drug development process.
    Versteegh LR
    Food Drug Law J; 1997; 52(2):155-61. PubMed ID: 10557552
    [No Abstract]   [Full Text] [Related]  

  • 9. Resolving the onset of antidepressants' clinical actions: critical for clinical practice and new drug development.
    Katz MM; Bowden CL; Berman N; Frazer A
    J Clin Psychopharmacol; 2006 Dec; 26(6):549-53. PubMed ID: 17110809
    [No Abstract]   [Full Text] [Related]  

  • 10. US watchdog finds bias against morning-after pill.
    Wadman M
    Nature; 2005 Nov; 438(7067):401. PubMed ID: 16306946
    [No Abstract]   [Full Text] [Related]  

  • 11. Establishing the real cost of depression.
    Sheehan DV
    Manag Care; 2002 Aug; 11(8 Suppl):7-10; discussion 21-5. PubMed ID: 12233202
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulator under siege.
    Wadman M
    Nature; 2007 Dec; 450(7173):1143. PubMed ID: 18097370
    [No Abstract]   [Full Text] [Related]  

  • 13. Moment of reckoning.
    Wadman M
    Nature; 2007 Apr; 446(7138):844-5. PubMed ID: 17443154
    [No Abstract]   [Full Text] [Related]  

  • 14. Trouble at the office.
    Allison M
    Nat Biotechnol; 2008 Sep; 26(9):967-9. PubMed ID: 18779797
    [No Abstract]   [Full Text] [Related]  

  • 15. Pregnancy and pills. New research finds prescriptions may be safer than you think.
    Schultz S
    US News World Rep; 1999 Apr; 126(13):64-6. PubMed ID: 10351523
    [No Abstract]   [Full Text] [Related]  

  • 16. What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval.
    Dodge T; Kaufman A
    Health Psychol; 2007 Jul; 26(4):513-7. PubMed ID: 17605572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better prioritization may speed approval of adjuvant therapies in breast cancer.
    Tuma RS
    J Natl Cancer Inst; 2008 Jun; 100(12):842-4. PubMed ID: 18544735
    [No Abstract]   [Full Text] [Related]  

  • 18. Wellbutrin versus generic bupropion.
    Med Lett Drugs Ther; 2008 Jul; 50(1290):54-5. PubMed ID: 18617874
    [No Abstract]   [Full Text] [Related]  

  • 19. Clarification: 510k is premarket notification; it provides no patent or FDA approval.
    Burkhart CG
    J Drugs Dermatol; 2008 Feb; 7(2):105. PubMed ID: 18335644
    [No Abstract]   [Full Text] [Related]  

  • 20. Beyond depression. What do those "mood drugs" really do?
    Lemonick MD
    Time; 1999 May; 153(19):74. PubMed ID: 10387666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.